CAB

BioAtla to Announce Fourth Quarter and Full-Year 2022 Financial Results and Provide Business Highlights

Retrieved on: 
Jeudi, mars 16, 2023
SAN, CAB, Therapy, Webcast, Conditional, Pharmaceutical industry

SAN DIEGO, March 16, 2023 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced that it plans to host a conference call and webcast on Thursday, March 23, 2023 at 4:30 p.m.

Key Points: 
  • SAN DIEGO, March 16, 2023 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced that it plans to host a conference call and webcast on Thursday, March 23, 2023 at 4:30 p.m.
  • ET to discuss its financial results for the fourth quarter and full-year ended December 31, 2022 and provide business highlights.

FRONTSTEPS Announces Strategic Hires to Enhance Investment and Growth

Retrieved on: 
Mercredi, mars 1, 2023
First Citizens Bank (Trinidad and Tobago), Peter, Community association manager, Software, Capital One, CAB, Princeps, Growth, CIT, Community association, Management, HOA, Marketing

With these hires, FRONTSTEPS is making a strong statement about its commitment to the future.

Key Points: 
  • With these hires, FRONTSTEPS is making a strong statement about its commitment to the future.
  • "FRONTSTEPS has the right culture, people and technology to win market share at an unprecedented rate" says Maher.
  • She led strategic growth initiatives and marketing communications that allowed our industry to take full advantage of advanced capital management and software integration strategies.
  • Knutson is leading all marketing and growth development efforts to help FRONTSTEPS support its existing clients and consistently reach new ones.

BioAtla Announces Change in Executive Leadership

Retrieved on: 
Lundi, février 27, 2023
Biotechnology, Knowledge, Therapy, SAN, CAB, Conditional, Management

Scott will continue his relationship with BioAtla by serving as a Board of Directors member for the Company.

Key Points: 
  • Scott will continue his relationship with BioAtla by serving as a Board of Directors member for the Company.
  • “We extend our sincere thanks to Scott for his important contributions since joining the Company in 2018 and wish him well in his new endeavor,” said Jay M. Short, Ph.D., Chairman, Chief Executive Officer and co-founder of BioAtla.
  • “Scott’s extensive experience in biotechnology and pharmaceutical executive leadership roles has helped the expansion of the Company’s operations and advancement of our pipeline and clinical programs.
  • I am proud of all that BioAtla has accomplished and the impact the Company continues to make in its mission to improve patients’ lives.

BioAtla Announces FDA Clearance of Investigational New Drug Application for BA3182, a CAB-EpCAMxCAB-CD3 Bispecific T-Cell Engager for the Treatment of Advanced Adenocarcinoma

Retrieved on: 
Jeudi, février 23, 2023
Epithelial cell adhesion molecule, Adenocarcinoma, Colon, Conditional, IND, CAB, FDA, Patient, Toxicity, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Cancer, Trial of the century, Pancreas, Therapy, SAN, Therapeutic index, TME, Tumor microenvironment, CD3, Breast, Food, Prostate, Lung, Pharmaceutical industry, Vaccine

BioAtla plans to initiate and advance a Phase 1 dose-escalation and expansion clinical study in 2023.

Key Points: 
  • BioAtla plans to initiate and advance a Phase 1 dose-escalation and expansion clinical study in 2023.
  • The high-level expression of EpCAM in solid tumors has made it an attractive target for antibody molecules to treat epithelial cancers, particularly adenocarcinomas.
  • In vivo studies with BA3182 indicate that the therapeutic index was improved more than 100-fold relative to non-CAB variants, supporting the potential differentiation of CAB bispecific antibodies versus more traditional bispecific antibodies.
  • “Our goal is to continue executing and pursuing indications with large unmet medical need that potentially have the highest impact for patients and our shareholders worldwide.

Cannabix Technologies to Test Contactless Alcohol Breathalyzer (CAB) in Montana

Retrieved on: 
Lundi, février 13, 2023
BAC, Restaurant, OTC, House, National Highway Traffic Safety Administration, Legislation, Safety, Workplace, Prohibition, National Transportation Safety Board, Patient, IIJA, Representative, Blood alcohol content, Australian Transport Safety Bureau, Louisiana House of Representatives, NTSB, Blood, Infrastructure Investment and Jobs Act, CSE, CAB, Pharmaceutical industry, Rail transport, Volvo

VANCOUVER, British Columbia, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of breath testing devices for law enforcement and the workplace reports that Friedel, LLC (“Friedel Clinic”) based in Montana will commence piloting Cannabix’s  Contactless Alcohol Breathalyzer (“CAB”).

Key Points: 
  • VANCOUVER, British Columbia, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of breath testing devices for law enforcement and the workplace reports that Friedel, LLC (“Friedel Clinic”) based in Montana will commence piloting Cannabix’s  Contactless Alcohol Breathalyzer (“CAB”).
  • The high-volume clinic has a diverse range of patients and focuses on private sector testing for alcohol and illicit drugs.
  • The Friedel Clinic has extensive experience piloting with new alcohol and drug testing technologies.
  • Montana Senator Chris Friedel stated, “The Friedel Clinic has been a pioneer in alcohol, drug and brain health testing in the state of Montana.

HAYA Therapeutics Adds World-Leading Cardiologist and Dark Genome Pioneer to Advisory Boards

Retrieved on: 
Jeudi, février 16, 2023
Biotechnology, Health, Other Health, Pharmaceutical, Oncology, Other Science, Research, General Health, Hospitals, Genetics, Health Technology, Science, Clinical Trials, Cardiology, DNA, SA, Jordan University of Science and Technology, Cornell University, Scientist, Virus, Assistant, Molecular biology, RNA, SAB, OHSU, Division, Patient, Listeria monocytogenes non-coding RNA, Biochemistry, Oregon Health & Science University, University, Therapy, Amyloidosis, Cardiac fibrosis, Medical school, Hypertrophic cardiomyopathy, Genomics, School, Multimedia, Cardiovascular disease, Cancer, CAB, IND, Vaccine, Pharmaceutical industry, Medicine

HAYA Therapeutics, SA , a company developing RNA-guided programmable precision medicines focused on long non-coding RNAs (lncRNAs), today announced that Ahmad Masri, M.D., M.S.

Key Points: 
  • HAYA Therapeutics, SA , a company developing RNA-guided programmable precision medicines focused on long non-coding RNAs (lncRNAs), today announced that Ahmad Masri, M.D., M.S.
  • View the full release here: https://www.businesswire.com/news/home/20230216005353/en/
    Dr. Ahmad Masri, a Cardiologist and Physician Scientist at the Oregon Health & Science University’s Knight Cardiovascular Institute, has been named the newest member of HAYA Therapeutic’s Clinical Advisory Board.
  • (Photo: Business Wire)
    “The expansion of our advisors with Ahmad and Cedric, and the creation of our Clinical Advisory Board marks a significant milestone for HAYA,” said Samir Ounzain, Ph.D., Co-founder and CEO of HAYA Therapeutics.
  • “HAYA has pioneered a novel approach of targeting disease drivers within the dark genome, and I’m looking forward to working with their team in identifying and understanding relevant clinically-translatable dark genome targets.”

United States Lawn and Garden Tractor Industry to 2027 - Key Players Include AriensCo, Deere & Company, Honda and Husqvarna - ResearchAndMarkets.com

Retrieved on: 
Mercredi, février 15, 2023
Machinery, Construction & Property, Manufacturing, Landscape, App Store (iOS/iPadOS), D, The Toro Company, Toro, Sport, Honda, Stanley Black & Decker, Husqvarna, MTD, AGCO, John Deere, CAB, Propane

Lawn and Garden Tractor Market - Industry Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • Lawn and Garden Tractor Market - Industry Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
  • The U.S. lawn and garden tractor market is expected grow at a CAGR of 4.13% from 2021-2027.
  • Vendors in the U.S. lawn and garden tractor market are integrating mobile applications with their tractors.
  • Other players operating in the U.S. lawn and garden tractor market include STIGA Group, AGCO, CAB CADET, Stanley Black & Decker, and others.

Onapsis Closes 2022 with Significant Momentum Driven by Accelerated Demand for Business Application Security

Retrieved on: 
Mercredi, février 15, 2023
Security, Apps, Applications, Technology, Software, Networks, Internet, Cloud, Software as a service, Cashman, Organization, DevOps, CDW, Adobe, Dow Chemical Company, Investment, Sony, ORL, Pfizer, Cargill, CAB, Microsoft, SAP, Workload, ERP, SAP SuccessFactors, Research, KPMG, Intelligence, Knowledge, HCM, Growth, Snyder, Dell EMC, CISA, McAfee, Colgate-Palmolive, Risk management, Oracle, Capgemini

“Attacks against business applications, such as SAP and Oracle, are growing at an exponential rate.

Key Points: 
  • “Attacks against business applications, such as SAP and Oracle, are growing at an exponential rate.
  • “Our goal is to give our customers the peace of mind of knowing their core business applications are secure, compliant, and available at all times.
  • There is nothing more important than protecting core business applications, and that is the problem Onapsis solves.
  • Onapsis further expanded its partner ecosystem, forming new strategic partnerships with leading organizations such as Oracle, KPMG, and Capgemini.

Identity Defined Security Alliance Appoints Jeff Reich to Executive Director, Announces Newly Elected Executive Advisory Board

Retrieved on: 
Mercredi, février 8, 2023
Cloud, Organization, British Computer Society, ISSA, IDSA, EAB, CISSP, CSA, The Council, Cloud Security Alliance, News, Information system, Certification, Distinguished Fellow of the British Computer Society, Risk, ISC, Security association, Growth, Education, Information Systems Security Association, Identity, ISACA, Customer advisory council, CAB, CRISC, Management, Audit, Target, Expedia, Comcast, Computer security, TikTok

DENVER, Feb. 8, 2023 /PRNewswire/ -- The Identity Defined Security Alliance (IDSA), a nonprofit that provides vendor-neutral resources to help organizations reduce the risk of a breach by combining identity and security strategies, today announced Jeff Reich as the organization's new Executive Director. Additionally, the organization recently elected the 2023/2024 Executive Advisory Board (EAB) and expanded its Customer Advisory Board (CAB) to include Comcast, Expedia, Target and TikTok.

Key Points: 
  • DENVER, Feb. 8, 2023 /PRNewswire/ -- The Identity Defined Security Alliance (IDSA), a nonprofit that provides vendor-neutral resources to help organizations reduce the risk of a breach by combining identity and security strategies, today announced Jeff Reich as the organization's new Executive Director.
  • Additionally, the organization recently elected the 2023/2024 Executive Advisory Board (EAB) and expanded its Customer Advisory Board (CAB) to include Comcast, Expedia, Target and TikTok.
  • Over the last few years, identity security has emerged as a top priority for most enterprises as identity-related breaches have dramatically increased.
  • IDSA Executive Advisory Board members:
    Ping Identity – Aubrey Turner, Executive Advisor
    "On behalf of the entire board, we are thrilled to have Jeff build on the great foundation that Julie has established," stated IDSA Board Member Julie Talbot-Hubbard.

Ultimate Ventures' General Manager Named to the ADMEI Hall of Fame

Retrieved on: 
Mercredi, février 8, 2023
Destination management, GMA Canada Lifetime Achievement Award, Professional, Bangladesh Accreditation Board, UV, Knowledge, DMC, Chair, Rising Star, Certification, Sales & Marketing Executives International, CAB, Property management

ADDISON, Texas, Feb. 8, 2023 /PRNewswire/ -- On Saturday, February 4, 2023, Beverly Brin received the Lifetime Achievement Award presented by the Association of Destination Management Executives International (ADMEI) during its annual conference held in Tampa, Florida. This prestigious award recognizes an individual who has given their time, dedication, leadership, and knowledge towards the advancement of the Destination Management (DMC) industry over their lifetime. 

Key Points: 
  • This prestigious award recognizes an individual who has given their time, dedication, leadership, and knowledge towards the advancement of the Destination Management (DMC) industry over their lifetime.
  • Beverly Brin, DMCP, General Manager of Ultimate Ventures (UV), earned this honor by being a consummate professional, a devoted friend, and a dedicated leader who has given much of herself during the last two decades to the DMC Industry.
  • Ultimate Ventures' President, Laurie Sprouse, followed up, "Beverly is an industry icon and so deserving of this honor.
  • It's impossible to sum up her contributions, but suffice it to say, we are so very grateful for her dedicated service to our company and the industry."